Company · CIK 1628171
Revolution Medicines, Inc.
| CIK | 1628171 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | RVMD (Nasdaq), RVMDW (Nasdaq) |
| First annual or quarterly report | 2020-03-30 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-277640 | 2024-03-04 | 2026-04-15 | 9 | |
| 333-279225 | 2024-05-08 | 2024-05-08 | 1 | |
| 333-253790 | 2021-03-02 | 2023-03-03 | 6 | |
| 333-252613 | 2021-02-01 | 2021-02-05 | 4 | |
| 333-239700 | 2020-07-06 | 2020-07-10 | 3 | |
| 333-235968 | 2020-01-17 | 2020-02-13 | 5 |
Filings
32| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-15 | 424B5Shelf takedown | 333-277640 | 0001193125-26-157273 |
| 2026-04-15 | 424B5Shelf takedown | 333-277640 | 0001193125-26-157268 |
| 2026-04-13 | 424B5Shelf takedown | 333-277640 | 0001193125-26-152978 |
| 2026-04-13 | 424B5Shelf takedown | 333-277640 | 0001193125-26-152972 |
| 2026-02-25 | 424B5Shelf takedown | 333-277640 | 0001193125-26-072036 |
| 2024-12-05 | 424B5Shelf takedown | 333-277640 | 0001193125-24-270818 |
| 2024-12-02 | 424B5Shelf takedown | 333-277640 | 0001193125-24-269027 |
| 2024-08-07 | 424B5Shelf takedown | 333-277640 | 0001193125-24-195978 |
| 2024-05-08 | S-3ASRShelf registered | 333-279225 | 0001193125-24-134347 |
| 2024-03-04 | S-3ASRShelf registered | 333-277640 | 0001193125-24-058009 |
| 2023-09-29 | EFFECTDeclared effective | 333-274499 | 9999999995-23-002895 |
| 2023-03-03 | 424B5Shelf takedown | 333-253790 | 0001193125-23-060029 |
| 2023-03-01 | 424B5Shelf takedown | 333-253790 | 0001193125-23-056526 |
| 2022-07-20 | 424B5Shelf takedown | 333-253790 | 0001193125-22-198093 |
| 2022-07-19 | 424B5Shelf takedown | 333-253790 | 0001193125-22-196961 |
| 2021-11-10 | 424B5Shelf takedown | 333-253790 | 0001193125-21-326067 |
| 2021-03-02 | S-3ASRShelf registered | 333-253790 | 0001193125-21-065612 |
| 2021-02-05 | 424B4Final prospectus | 333-252613 | 0001193125-21-029250 |
| 2021-02-03 | EFFECTDeclared effective | 333-252613 | 9999999995-21-000426 |
| 2021-02-03 | S-1/AAmendment | 333-252613 | 0001193125-21-026326 |
| 2021-02-01 | S-1Registration filed | 333-252613 | 0001193125-21-024544 |
| 2021-01-21 | DRSDraft made public | 377-04066 | 0000950131-21-000390 |
| 2020-07-10 | 424B4Final prospectus | 333-239700 | 0001193125-20-190627 |
| 2020-07-08 | EFFECTDeclared effective | 333-239700 | 9999999995-20-001722 |
| 2020-07-06 | S-1Registration filed | 333-239700 | 0001193125-20-187824 |
| 2020-06-09 | DRSDraft made public | 377-03205 | 0000950123-20-006109 |
| 2020-02-13 | 424B4Final prospectus | 333-235968 | 0001193125-20-035507 |
| 2020-02-12 | EFFECTDeclared effective | 333-235968 | 9999999995-20-000334 |
| 2020-02-11 | S-1/AAmendment | 333-235968 | 0001193125-20-030511 |
| 2020-02-03 | S-1/AAmendment | 333-235968 | 0001193125-20-022117 |
| 2020-01-17 | S-1Registration filed | 333-235968 | 0001193125-20-010145 |
| 2019-09-19 | DRSDraft made public | 377-02838 | 0000950123-19-009013 |